Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Revue Neurologique|January 1, 1989
[Extrapyramidal syndrome after cardiocirculatory incompetence]M C Durand, J B Vercken, M Goulon
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Study design, methodology and statistical analyses in the clinical development of sparfloxacinE Genevois, V Lelouer, J B Vercken, et al.
Scandinavian Journal of Infectious Diseases|January 1, 1995
Severe community-acquired pneumococcal pneumonia. The French Study Group of Community-Acquired Pneumonia in ICUP Moine, J B Vercken, S Chevret, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 1998
Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study GroupM Aubier, R Verster, C Regamey, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1988
Adult maltase acid deficiency myopathy: treatment with long-term home mechanical ventilationJ B Vercken, J C Raphael, J de Lattre, et al.
Revue De Pneumologie Clinique|January 1, 1992
[Community-acquired pneumonia in healthy adults: 188 patients treated with spiramycin in private practice]L Jeannin, J Vergeret, D Caillaud, et al.
Lancet (London, England)|August 19, 1989
Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxicationJ C Raphael, D Elkharrat, M C Jars-Guincestre, et al.
Revue De Pneumologie Clinique|January 1, 1994
[Treatment of community-acquired pneumonia by pristinamycin (Pyostacine 500). Results of a non comparative open study]P Petitpretz, J C Guerin, G Nouvet, et al.
Pageof 2